Edition:
India

OvaScience Inc (OVAS.OQ)

OVAS.OQ on NASDAQ Stock Exchange Global Market

1.09USD
19 Jan 2018
Change (% chg)

$-0.01 (-0.91%)
Prev Close
$1.10
Open
$1.11
Day's High
$1.11
Day's Low
$1.08
Volume
42,537
Avg. Vol
67,437
52-wk High
$2.05
52-wk Low
$1.08

Latest Key Developments (Source: Significant Developments)

Ovascience Says ‍Reducing Headcount By Approximately 50 Percent​
Thursday, 4 Jan 2018 

Jan 3 (Reuters) - Ovascience Inc ::OVASCIENCESM ANNOUNCES CORPORATE UPDATE.OVASCIENCE INC - ‍REDUCING HEADCOUNT BY APPROXIMATELY 50 PERCENT​.OVASCIENCE INC - ‍MAJORITY OF REDUCTION IN PERSONNEL IS EXPECTED TO BE COMPLETED BY MARCH 2018​.OVASCIENCE INC - JAMES LILLIE JOINING AS CHIEF SCIENTIFIC OFFICER.OVASCIENCE INC - ‍AS A RESULT OF REDUCTION IN PERSONNEL, CO EXPECTS TO REALIZE ANNUALIZED COST SAVINGS BEGINNING IN Q2 OF 2018​.OVASCIENCE INC - ‍ESTIMATES THAT IT WILL INCUR ONE-TIME COSTS OF APPROXIMATELY $1.0 MILLION TO $1.5 MILLION RELATED TO RESTRUCTURING PLAN​.OVASCIENCE INC - ‍PLANS TO INITIATE A MULTI-CENTER, PROSPECTIVE, CONTROLLED, PHASE 1B/2A CLINICAL TRIAL OF OVAPRIME​.OVASCIENCE INC - ‍EXPECTS TO BEGIN PATIENT ENROLLMENT IN FIRST HALF OF 2018 AND TO REPORT INITIAL CLINICAL DATA IN 2019​ FROM PLANNED OVAPRIME TRIAL.  Full Article

Ovascience reports Q3 loss per share $0.26
Friday, 3 Nov 2017 

Nov 2 (Reuters) - Ovascience Inc :Ovascience reports third quarter 2017 financial results.Q3 loss per share $0.26.Q3 earnings per share view $-0.40 -- Thomson Reuters I/B/E/S.Ovascience Inc - ‍expects to incur additional cash outlays related to restructurings of between $1.0 million and $1.5 million over 2017 and 2018​.Ovascience Inc - ‍anticipates that it will have sufficient funds without additional financing to support its operations into q1 of 2020​.  Full Article

Ovascience names Christophe Couturier as CFO
Wednesday, 7 Sep 2016 

Ovascience Inc : Christophe Couturier has been named chief financial officer, effective immediately .Christophe couturier succeeds Jeff Young, who is pursuing other opportunities and will be leaving ovascience after a transition period.  Full Article

Ovascience Q2 loss per share $0.62
Friday, 5 Aug 2016 

Ovascience Inc : Q2 earnings per share view $-0.78 -- Thomson Reuters I/B/E/S . Ovascience reports second quarter 2016 financial results . Q2 loss per share $0.62 .Ovascience reports second quarter 2016 financial results.  Full Article

Ovascience says offering of 7.2 mln shares priced at $7/share
Thursday, 26 May 2016 

Ovascience Inc : Ovascience announces pricing of public offering of common stock .Says priced its previously announced underwritten public offering of 7.2 million shares of its common stock at $7.00 per share.  Full Article

Ovascience says commenced public offering of common stock
Thursday, 26 May 2016 

Ovascience Inc : To use proceeds to fund commercial expansion of augment treatment in key regions, ongoing pre-commercial activities for Ovaprime .Ovascience announces proposed public offering of common stock.  Full Article

Ovascience director Richard Aldrich reports purchase of stock
Friday, 20 May 2016 

Ovascience Inc : Director Richard Aldrich reports purchase of 20,000 shares of co's common stock on May 18 at average price $7.86 per share - sec filing .Director Aldrich's purchase of co's stock reflects purchase of the shares by Longwood Fund III LP, according to form 4 filing.  Full Article